📊 PHGE Key Takeaways
Is BiomX Inc. (PHGE) a Good Investment?
BiomX is in severe financial distress with negative stockholders equity (-$881K), indicating liabilities exceed assets, coupled with negative operating cash flow (-$5.4M) that cannot service $11.2M in long-term debt. The company appears to have little to no revenue while burning significant cash, leaving approximately 2-3 months of runway at current burn rate.
BiomX Inc. Key Strengths (PHGE)
- Minimal capital expenditure ($2K) reduces cash drain from expansion
- Current ratio of 1.24x provides marginal short-term liquidity coverage
- Small asset base ($3.3M) limits downside exposure
PHGE Stock Risks: BiomX Inc. Investment Risks
- Negative stockholders equity indicates technical insolvency from balance sheet perspective
- Operating cash flow of -$5.4M with only $1.2M cash creates imminent liquidity crisis within months
- Long-term debt of $11.2M cannot be serviced; negative interest coverage of -1.5x
- Absence of revenue data suggests pre-revenue or failed commercialization
- ROA of -588.7% reflects severe asset inefficiency and value destruction
Key Metrics to Watch
- Cash burn rate and months of cash runway remaining
- Revenue generation or announcement of significant capital infusion
- Restructuring announcements or debt refinancing negotiations
BiomX Inc. (PHGE) Financial Metrics & Key Ratios
💡 AI Analyst Insight
BiomX Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
PHGE Profit Margin, ROE & Profitability Analysis
PHGE vs Healthcare Sector: How BiomX Inc. Compares
How BiomX Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is BiomX Inc. Stock Overvalued? PHGE Valuation Analysis 2026
Based on fundamental analysis, BiomX Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
BiomX Inc. Balance Sheet: PHGE Debt, Cash & Liquidity
PHGE Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: BiomX Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $58.31 reflects profitable operations.
PHGE Revenue Growth, EPS Growth & YoY Performance
BiomX Inc. Dividends, Buybacks & Capital Allocation
PHGE SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for BiomX Inc. (CIK: 0001739174)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PHGE
What is the AI rating for PHGE?
BiomX Inc. (PHGE) has an AI grade of D with 88% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PHGE's key strengths?
Claude: Minimal capital expenditure ($2K) reduces cash drain from expansion. Current ratio of 1.24x provides marginal short-term liquidity coverage.
What are the risks of investing in PHGE?
Claude: Negative stockholders equity indicates technical insolvency from balance sheet perspective. Operating cash flow of -$5.4M with only $1.2M cash creates imminent liquidity crisis within months.
What is PHGE's revenue and growth?
BiomX Inc. reported revenue of N/A.
Does PHGE pay dividends?
BiomX Inc. does not currently pay dividends.
Where can I find PHGE SEC filings?
Official SEC filings for BiomX Inc. (CIK: 0001739174) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PHGE's EPS?
BiomX Inc. has a diluted EPS of $7.38.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PHGE's fundamental grade?
Based on our AI fundamental analysis in May 2026, BiomX Inc. has a D grade with 88% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PHGE stock overvalued or undervalued?
Valuation metrics for PHGE: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is PHGE's AI grade for 2026?
Our dual AI analysis gives BiomX Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PHGE's free cash flow?
BiomX Inc.'s operating cash flow is $-5.4M, with capital expenditures of $2.0K.
How does PHGE compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 1.24 (avg: 2).